Related Experiment Video
Updated: May 20, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Bleeding Phenotypes in Inherited Platelet Function Disorders: Insights From the ATHNdataset
Divyaswathi Citla-Sridhar1, Jianzhong Hu2, Robert F Sidonio3
1Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, AR.
This study reveals significant bleeding and treatment patterns in inherited platelet function disorders (IPFDs), highlighting the need for improved diagnostic precision and patient care.
Area of Science:
- Hematology
- Genetics
- Clinical Medicine
Background:
- Inherited platelet function disorders (IPFDs) are rare and diverse, presenting diagnostic and management difficulties.
- Glanzmann thrombasthenia (GT) and Bernard-Soulier syndrome (BSS) bleeding is known, but milder or unclassified IPFDs are poorly understood.
Purpose of the Study:
- To analyze bleeding phenotypes, treatment strategies, and diagnostic distribution of IPFDs in the U.S. using the ATHNdataset.
- To characterize clinical outcomes for patients with IPFDs from 2013-2022.
Main Methods:
- Retrospective cohort study utilizing the deidentified ATHNdataset.
- Analysis of clinical outcomes, bleeding events, laboratory data, treatments, and procedures for IPFD patients with active follow-up (2021-2022).
Main Results:
- Over 2300 individuals had IPFDs, with 81.6% classified as IPFD-other.
- Epistaxis, soft tissue, and oral bleeding were most common; intracranial hemorrhage and joint bleeds occurred in 8 and 82 patients, respectively.
- Elevated ISTH-BAT scores noted across subtypes, with antifibrinolytics being the most common treatment.
Conclusions:
- The study defines the clinical spectrum, treatment use, and diagnostic gaps in IPFDs.
- Emphasizes the critical need for enhanced diagnostic accuracy and improved care for patients with platelet function disorders.
More Related Videos
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Pedigree Analysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

